NATCO Pharma per share figures

Share price at each year-end
Tap a line for its trendCurrentlast 12MFY26Mar 2026FY25Mar 2025FY24Mar 2024FY23Mar 2023FY22 and earlierAlpha Plus
₹63.89₹79.20₹105.26₹77.34₹39.18
FY22 and earlierEvery year the company has filed comes with Alpha Plus.
₹63.89₹79.20₹105.26₹77.34₹39.18
₹515.15₹515.15₹424.97₹326.99₹267.06
₹194.67₹227.84₹247.46₹223.40₹148.33
—₹98.79₹94.79₹67.69₹46.53
₹76.94₹76.94₹66.21₹47.65₹35.26
—₹5.04₹6.02₹9.54₹5.50
17.917.917.917.918.3
Open the chart

From the company's filings with NSE and BSE (Ind-AS), consolidated. For information only, not investment advice.

NATCOPHARM₹793.00

NATCO Pharma Ltd.

· Pharma & Health
₹ CrorePeersDRREDDYZYDUSLIFESUNPHARMALALPATHLABNEULANDLABNHSAILIFECOHANCEMcap ₹14,195 Cr
HighlightsEnterprise ValueMultiplesPer ShareAnnuals · FY-end closes
₹ per share
12 Months Ending
FY23
31/03/2023
FY24
31/03/2024
FY25
31/03/2025
FY26
31/03/2026
Current/LTM
TTM · last close
Basic EPS39.1877.34105.2679.2063.89
Diluted EPS39.1877.34105.2679.2063.89
Book Value per Share267.06326.99424.97515.15515.15
Revenue per Share148.33223.40247.46227.84194.67
Cash Flow per Share46.5367.6994.7998.79—
Free Cash Flow per Share35.2647.6566.2176.9476.94
Dividends per Share5.509.546.025.04—
Shares Outstanding (cr)18.317.917.917.917.9
Market Cap/EV/multiples pair each (split/bonus-adjusted) FY-end close with the latest filed share count; Current column uses the last close. Market Capitalization is a market-level figure — identical across Consolidated/Standalone (the accounting rows below differ). No consensus estimates → no Est columns. Click any row to chart it.
« ‹ › »Latest: FY26 · ConsolidatedFA Financial Analysis · alphave
Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreement — XBRL cross-verified ✓ 95%.